Results 161 to 170 of about 55,450 (260)

Immunogenicity and safety of co-administered <i>Escherichia coli</i>-produced bivalent HPV-16/18 vaccine and hepatitis E vaccine. [PDF]

Front Immunol
Yan R, Cen M, Zhou Y, Ma L, Zhou X, He H, Qi X, Tang X, Liang H, Chen Y, Qi J, Yang S.   +11 more
europepmc   +1 more source

Hepatitis C Virus Infection in the PERSIAN Guilan Cohort Study Population: Intrafamilial Transmission Incidence and Response to SOVODAK‐Based Therapy

Health Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background Hepatitis C virus (HCV) infection is one of the leading causes of liver‐related diseases such as cirrhosis and hepatocellular carcinoma. Despite ongoing efforts, no effective vaccine has been developed to date due to the virus's high mutation rate and extensive genetic variability. This study aimed to determine the prevalence of HCV
Farahnaz Joukar, Sara Yeganeh, Narges Eslami, Fariborz Mansour‐Ghanaei   +3 more
wiley   +1 more source

Towards HDV Elimination Through HBV Vaccination: Global Strategies, Challenges, and Policy Gaps. [PDF]

Vaccines (Basel)
Batbold E, Dashdorj N, Zoulim F, Bartosch B.   +3 more
europepmc   +1 more source

In Silico Design and Computational Characterization of Novel Chimeric Multiepitope Antigens for Mpox Serosurveillance: An Immunoinformatics Approach

Health Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background and Aims The Monkeypox (Mpox) virus is a zoonotic Orthopoxvirus with a global outbreak that began in 2022, with more than 132,000 confirmed cases and 1500 deaths across over 128 countries. The pandemic preparedness pipeline emphasizes the importance of diagnostic surveillance of pathogens in at‐risk populations to monitor ...
Roland Ngwese Akwelle, Robert Adamu Shey, Mary Teke Efeti, Lekeayi Nelson Acha, Gordon Takop Nchanji, Yanick Aqua Stong Tangan, Joan Amban Chick, Ntang Emmaculate Yaah, Lahngong Methodius Shinyuy, Cabirou Mounchili Shintouo, Bernis Neneyoh Yengo, Abey Blessings Ayuk, Junior Ekunidi Engarimbi, Ketura Yaje Gwei, Brinate Teke Tebo, Derrick Neba Nebangwa, Beltine Muyer Tamnjong, Luc Vanhamme, Jacob Souopgui, Vincent P. K. Titanji, Stephen Mbigha Ghogomu   +20 more
wiley   +1 more source

Precore/core mutation relatedness to viral reactivation in patients undergoing targeted therapy for hepatitis B virus-related hepatocellular carcinoma. [PDF]

World J Biol Chem
Abdulrahman MS, Aboelmagd O, Zhang Y, Zaky S, Johar D.   +4 more
europepmc   +1 more source

Hepatitis B Vaccination Coverage and Associated Factors Among Healthcare Workers: A Cross‐Sectional Study

Health Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background Hepatitis B virus (HBV) infection is a major occupational hazard among healthcare workers (HCWs), particularly in resource‐limited settings where vaccination coverage remains low. This study aimed to assess hepatitis B vaccination coverage and associated factors among healthcare workers.
Melaku Zewdu Yehualaw, Habtie Bantider Wubet, Negesse Zurbachew Gobezie, Nigist Ali Tegegn, Kaletsidk Desalegn Mossie, Shimelis Seid Tegegne, Alemie Fentie Mebratie, Begizew Yimenu Mekuriaw   +7 more
wiley   +1 more source

Hepatitis B vaccination at birth: science, myths, and the safety net imperative. [PDF]

Front Immunol
Gupta RK.
europepmc   +1 more source

Virus Biomimetic-Delivery Systems for the Production of Vaccines. [PDF]

Biomimetics (Basel)
Barbinta-Patrascu ME, Negut I, Bita B.
europepmc   +1 more source

Epidemiological Trends and Clinical Characteristics of Epstein–Barr Virus Infection in Febrile Children in Zhejiang, China: A Retrospective Study

Immunity, Inflammation and Disease, Volume 14, Issue 6, June 2026.
ABSTRACT Background This study aimed to investigate the epidemiological trends, age‐ and sex‐related patterns, and clinical and immunological characteristics of Epstein–Barr virus (EBV) infection among febrile children. Methods We analyzed EBV DNA data from 9151 febrile children and serological antibody profiles from 6934 cases.
Hao Zhou, Xuanwen Ru, Wenqin Jin, Simiao Chen, Qing Ye   +4 more
wiley   +1 more source

Durable protection against lethal Rift Valley fever hepatitis and encephalitis following low-dose ΔNSsΔNSm vaccination in mice. [PDF]

mSphere
Mueller Brown K, Kindsvogel AM, Xu L, Divens AM, McElroy AK.   +4 more
europepmc   +1 more source